| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 7e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |